Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › [1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes

[1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes

US Patent 11401274 · Granted Aug 2, 2022

Estimated economic value: $1,780,908,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

IL-17A inhibitors2025
AHR agonists2024
Heterocyclic compounds and related methods2024
Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors2022
[1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives2021
[1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives2021
[1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives2021
Azetidinyloxyphenylpyrrolidine compounds2020
Substituted tetrahydrocarbazole and carbazole carboxamide compounds2019
Bicyclic heteroaryl amine compounds2019
Triazolopyrazinone derivative useful as a human PDE1 inhibitor2018
Substituted tetrahydrocarbazole and carbazole carboxamide compounds2018